Kantarjian H - Search Results

1

Guadecitabine vs treatment choice in newly diagnosed acute myeloid leukemia: a global phase 3 randomized study.

Fenaux P, Gobbi M, Kropf PL, Issa JJ, Roboz GJ, Mayer J, Krauter J, Robak T, Kantarjian H, Novak J, Jedrzejczak WW, Thomas X, Ojeda-Uribe M, Miyazaki Y, Min YH, Yeh SP, Brandwein J, Gercheva-Kyuchukova L, Demeter J, Griffiths E, Yee K, Döhner K, Hao Y, Keer H, Azab M, Döhner H. Fenaux P, et al. Among authors: kantarjian h. Blood Adv. 2023 Sep 12;7(17):5027-5037. doi: 10.1182/bloodadvances.2023010179. Blood Adv. 2023. PMID: 37276510 Free PMC article. Clinical Trial.

2

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA).

Estey EH, Kurzrock R, Kantarjian HM, O'Brien SM, McCredie KB, Beran M, Koller C, Keating MJ, Hirsch-Ginsberg C, Huh YO, et al. Estey EH, et al. Among authors: kantarjian hm. Blood. 1992 Feb 15;79(4):882-7. Blood. 1992. PMID: 1346577 Free article.

3

Fludarabine therapy in macroglobulinemic lymphoma.

Kantarjian HM, Alexanian R, Koller CA, Kurzrock R, Keating MJ. Kantarjian HM, et al. Blood. 1990 May 15;75(10):1928-31. Blood. 1990. PMID: 1692487 Free article.

4

Intensive chemotherapy with mitoxantrone and high-dose cytosine arabinoside followed by granulocyte-macrophage colony-stimulating factor in the treatment of patients with acute lymphocytic leukemia.

Kantarjian HM, Estey EH, O'Brien S, Anaissie E, Beran M, Rios MB, Keating MJ, Gutterman J. Kantarjian HM, et al. Blood. 1992 Feb 15;79(4):876-81. Blood. 1992. PMID: 1737098 Free article.

5

Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemia.

Kantarjian HM, Talpaz M, Dhingra K, Estey E, Keating MJ, Ku S, Trujillo J, Huh Y, Stass S, Kurzrock R. Kantarjian HM, et al. Blood. 1991 Nov 1;78(9):2411-8. Blood. 1991. PMID: 1932753 Free article.

6

Mixed-lineage leukemia revisited: acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy.

Kantarjian HM, Hirsch-Ginsberg C, Yee G, Huh Y, Freireich EJ, Stass S. Kantarjian HM, et al. Blood. 1990 Aug 15;76(4):808-13. Blood. 1990. PMID: 2166608 Free article.

7

Treatment of poor-prognosis, newly diagnosed acute myelogenous leukemia with high-dose cytosine arabinoside (Ara-C) and rHUGM-CSF.

Estey EH, Kantarjian HM, Beran M, McCredie KB, Keating MJ, Deisseroth A, Gutterman JU. Estey EH, et al. Among authors: kantarjian hm. Haematol Blood Transfus. 1990;33:732-6. doi: 10.1007/978-3-642-74643-7_134. Haematol Blood Transfus. 1990. PMID: 2182463

8

Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony-stimulating factor.

Estey EH, Dixon D, Kantarjian HM, Keating MJ, McCredie K, Bodey GP, Kurzrock R, Talpaz M, Freireich EJ, Deisseroth AB, et al. Estey EH, et al. Among authors: kantarjian hm. Blood. 1990 May 1;75(9):1766-9. Blood. 1990. PMID: 2184901 Free article.

9

Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia.

Kantarjian HM, Walters RS, Smith TL, Keating MJ, Barlogie B, McCredie KB, Freireich EJ. Kantarjian HM, et al. Blood. 1988 Nov;72(5):1784-9. Blood. 1988. PMID: 3052630 Free article.

10

The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia.

Cortes J, O'Brien SM, Pierce S, Keating MJ, Freireich EJ, Kantarjian HM. Cortes J, et al. Among authors: kantarjian hm. Blood. 1995 Sep 15;86(6):2091-7. Blood. 1995. PMID: 7662956 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,505 results

Search Page